Clinical Trial Update: Study to Assess PK, Safety and Tolerability in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to assess pharmacokinetics, safety and tolerability in healthy subjects. The trial lists Acute ischemic stroke as the condition and is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Changzhou Qianhong Bio-pharma Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 1 | Status: COMPLETED